MedTrace Logo

Clinical Trial of Acupoint Application in Improving the Sequelae of Pelvic Inflammatory Disease and Chronic Pelvic Pain

NCT06360965 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-04-11

No results posted yet for this study

Summary

Chronic Pelvic Pain is one of the common gynecological symptoms, characterized by persistent and non periodic pain in the pelvic cavity and surrounding tissues. It is often seen as a sequelae of pelvic inflammatory diseases caused by the failure to receive timely and correct treatment. This study compares the effectiveness of warm meridians and relieve pain plaster in relieving the sequelae of pelvic inflammatory disease and chronic pelvic pain symptoms, and evaluates the safety of improved patches and traditional patches, further promoting it to community grassroots hospitals.

Conditions

  • Pelvic Inflammatory Disease
  • Chronic Pelvic Pain Syndrome

Interventions

DRUG

Improved warm meridians and relieve pain plaster

Starting from the 1st to 3rd day after the menstrual cycle is clean, apply it 6-8 hours before bedtime every day, with one day off. Apply 10 times per menstrual cycle as one course of treatment, with two consecutive courses of treatment.

DRUG

Traditional warm meridians and relieve pain plaster

The treatment course is the same as the improved warm meridians and relieve pain plaster group.

DRUG

Placebo plaster

The treatment course is the same as the improved warm meridians and relieve pain plaster group.

Sponsors & Collaborators

  • Beijing Hospital of Integrated Traditional Chinese and Western Medicine

    lead OTHER

Principal Investigators

  • Yu Cao, Master · Beijing Hospital of Integrated Traditional Chinese and Western Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-01-01
Primary Completion
2026-03-31
Completion
2026-12-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06360965 on ClinicalTrials.gov